価格表

在庫・価格 : 2024年06月19日 18時34分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-PPAR Gamma (ser273) Polyclonal Antibody
データシート
bs-4888R BISバイオス
Bioss Inc
100 μl ¥64,000 1個 追加

在庫・価格 : 2024年06月19日 18時34分 現在

Anti-PPAR Gamma (ser273) Polyclonal Antibody

  • 商品コード:bs-4888R
  • メーカー:BIS
  • 包装:100μl
  • 価格: ¥64,000
  • 在庫:1個
使用文献
No. 文献情報 備考 参照
1 Kolli V et al. Partial agonist, telmisartan, maintains PPARγ serine 112 phosphorylation, and does not affect osteoblast differentiation and bone mass. PLoS ONE 2014;9(5):e96323
Kolli V et al
2014/01/01
PubMed
2 Pandurangan M et al. Aspartame downregulates 3T3-L1 differentiation. In Vitro Cell. Dev. Biol. Anim. 2014 Oct;50(9):851-7
Pandurangan M et al
2014/01/01
PubMed
3 Liu C et al. Identification of a novel selective agonist of PPARγ with no promotion of adipogenesis and less inhibition of osteoblastogenesis. Sci Rep 2015;5:9530
Liu C et al
2015/01/01
Sample_Species: Mouse, Application_Area: WB PubMed
4 Agrawal S et al. Pioglitazone Enhances the Beneficial Effects of Glucocorticoids in Experimental Nephrotic Syndrome. Sci Rep 2016;6:24392
Agrawal S et al
2016/01/01
applications: IHC-P, cross_reactive_species: Rat, sample_tissue: Kidney Glomeruli PubMed
5 Stechschulte LA et al. Protein Phosphatase PP5 Controls Bone Mass and the Negative Effects of Rosiglitazone on Bone through Reciprocal Regulation of PPARγ and RUNX2. J. Biol. Chem. 2016 Sep;
Stechschulte LA et al
2016/01/01
applications: WB, cross_reactive_species: Mouse, sample_tissue: Bone PubMed
6 Maganti AV et al. Peroxisome Proliferator-Activated Receptor-γ Activation Augments the β Cell Unfolded Protein Response and Rescues Early Glycemic Deterioration and β Cell Death in Non-Obese Diabetic Mice. J. Biol. Chem. 2016 Sep;
Maganti AV et al
2016/01/01
applications: WB, cross_reactive_species: Mouse, sample_cell_line: MIN6 cells PubMed
7 Abd Alla J et al. Inhibition of G-protein-coupled Receptor Kinase 2 Prevents the Dysfunctional Cardiac Substrate Metabolism in Fatty Acid Synthase Transgenic Mice. J. Biol. Chem. 2016 Feb;291(6):2583-600
Abd Alla J et al
2016/01/01
applications: WB, cross_reactive_species: Mouse, sample_tissue: cardiac tissue PubMed
8 Liu L et al. Dihydromyricetin delays the onset of hyperglycemia and ameliorates insulin resistance without excessive weight gain in Zucker diabetic fatty rats. Mol. Cell. Endocrinol. 2016 Oct;
Liu L et al
2016/01/01
applications: WB, cross_reactive_species: Rat PubMed
9 Sarr O et al. Low birth weight male guinea pig offspring display increased visceral adiposity in early adulthood. PLoS ONE 2014;9(6):e98433
Sarr O et al
2014/01/01
applications: WB, cross_reactive_species: Guinea Pig PubMed
10 Liu L et al. Dihydromyricetin enhances glucose uptake by inhibition of MEK/ERK pathway and consequent down-regulation of phosphorylation of PPARγ in 3T3-L1 cells. J. Cell. Mol. Med. 2018 02;22(2):1247-1256
Liu L et al
2018/01/01
applications: WB, cross_reactive_species: Mouse PubMed
11 Hou Y et al. CMHX008, a PPARγ partial agonist, enhances insulin sensitivity with minor influences on bone loss. Genes Dis 2018 Sep;5(3):290-299
Hou Y et al
2018/01/01
applications: WB, cross_reactive_species: Mouse PubMed
12 Liu Y et al. Isolation and characterization of ovine monocyte-derived macrophages from peripheral blood. Vet. Immunol. Immunopathol. 2018 Nov;205:83-92
Liu Y et al
2018/01/01
applications: IF, cross_reactive_species: Sheep PubMed
13 Li B et al. Resistin up-regulates LPL expression through the PPARγ-dependent PI3K/AKT signaling pathway impacting lipid accumulation in RAW264.7 macrophages. Cytokine 2019 Jul;119:168-174
Li B et al
2019/01/01
applications: WB, cross_reactive_species: Mouse PubMed
14 Zhang C et al. Osteoprotegerin Promotes Liver Steatosis by Targeting the ERK-PPAR-γ-CD36 Pathway. Diabetes 2019 10;68(10):1902-1914
Zhang C et al
2019/01/01
PubMed
15 Huan Y et al. A novel specific peroxisome proliferator-activated receptor γ (PPARγ) modulator YR4-42 ameliorates hyperglycaemia and dyslipidaemia and hepatic steatosis in diet-induced obese mice. Diabetes Obes Metab 2019 11;21(11):2553-2563
Huan Y et al
2019/01/01
PubMed
  • No.: 1
  • 文献情報:
    Kolli V et al. Partial agonist, telmisartan, maintains PPARγ serine 112 phosphorylation, and does not affect osteoblast differentiation and bone mass. PLoS ONE 2014;9(5):e96323
    Kolli V et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Pandurangan M et al. Aspartame downregulates 3T3-L1 differentiation. In Vitro Cell. Dev. Biol. Anim. 2014 Oct;50(9):851-7
    Pandurangan M et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Liu C et al. Identification of a novel selective agonist of PPARγ with no promotion of adipogenesis and less inhibition of osteoblastogenesis. Sci Rep 2015;5:9530
    Liu C et al
    2015/01/01
  • 備考:
    Sample_Species: Mouse, Application_Area: WB
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Agrawal S et al. Pioglitazone Enhances the Beneficial Effects of Glucocorticoids in Experimental Nephrotic Syndrome. Sci Rep 2016;6:24392
    Agrawal S et al
    2016/01/01
  • 備考:
    applications: IHC-P, cross_reactive_species: Rat, sample_tissue: Kidney Glomeruli
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Stechschulte LA et al. Protein Phosphatase PP5 Controls Bone Mass and the Negative Effects of Rosiglitazone on Bone through Reciprocal Regulation of PPARγ and RUNX2. J. Biol. Chem. 2016 Sep;
    Stechschulte LA et al
    2016/01/01
  • 備考:
    applications: WB, cross_reactive_species: Mouse, sample_tissue: Bone
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Maganti AV et al. Peroxisome Proliferator-Activated Receptor-γ Activation Augments the β Cell Unfolded Protein Response and Rescues Early Glycemic Deterioration and β Cell Death in Non-Obese Diabetic Mice. J. Biol. Chem. 2016 Sep;
    Maganti AV et al
    2016/01/01
  • 備考:
    applications: WB, cross_reactive_species: Mouse, sample_cell_line: MIN6 cells
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Abd Alla J et al. Inhibition of G-protein-coupled Receptor Kinase 2 Prevents the Dysfunctional Cardiac Substrate Metabolism in Fatty Acid Synthase Transgenic Mice. J. Biol. Chem. 2016 Feb;291(6):2583-600
    Abd Alla J et al
    2016/01/01
  • 備考:
    applications: WB, cross_reactive_species: Mouse, sample_tissue: cardiac tissue
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Liu L et al. Dihydromyricetin delays the onset of hyperglycemia and ameliorates insulin resistance without excessive weight gain in Zucker diabetic fatty rats. Mol. Cell. Endocrinol. 2016 Oct;
    Liu L et al
    2016/01/01
  • 備考:
    applications: WB, cross_reactive_species: Rat
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Sarr O et al. Low birth weight male guinea pig offspring display increased visceral adiposity in early adulthood. PLoS ONE 2014;9(6):e98433
    Sarr O et al
    2014/01/01
  • 備考:
    applications: WB, cross_reactive_species: Guinea Pig
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Liu L et al. Dihydromyricetin enhances glucose uptake by inhibition of MEK/ERK pathway and consequent down-regulation of phosphorylation of PPARγ in 3T3-L1 cells. J. Cell. Mol. Med. 2018 02;22(2):1247-1256
    Liu L et al
    2018/01/01
  • 備考:
    applications: WB, cross_reactive_species: Mouse
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Hou Y et al. CMHX008, a PPARγ partial agonist, enhances insulin sensitivity with minor influences on bone loss. Genes Dis 2018 Sep;5(3):290-299
    Hou Y et al
    2018/01/01
  • 備考:
    applications: WB, cross_reactive_species: Mouse
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Liu Y et al. Isolation and characterization of ovine monocyte-derived macrophages from peripheral blood. Vet. Immunol. Immunopathol. 2018 Nov;205:83-92
    Liu Y et al
    2018/01/01
  • 備考:
    applications: IF, cross_reactive_species: Sheep
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Li B et al. Resistin up-regulates LPL expression through the PPARγ-dependent PI3K/AKT signaling pathway impacting lipid accumulation in RAW264.7 macrophages. Cytokine 2019 Jul;119:168-174
    Li B et al
    2019/01/01
  • 備考:
    applications: WB, cross_reactive_species: Mouse
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Zhang C et al. Osteoprotegerin Promotes Liver Steatosis by Targeting the ERK-PPAR-γ-CD36 Pathway. Diabetes 2019 10;68(10):1902-1914
    Zhang C et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Huan Y et al. A novel specific peroxisome proliferator-activated receptor γ (PPARγ) modulator YR4-42 ameliorates hyperglycaemia and dyslipidaemia and hepatic steatosis in diet-induced obese mice. Diabetes Obes Metab 2019 11;21(11):2553-2563
    Huan Y et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed